These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Role of the initial level of plasminogen activator in changes in fibrinolysis]. Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132 [TBL] [Abstract][Full Text] [Related]
9. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma]. Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741 [TBL] [Abstract][Full Text] [Related]
10. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641 [TBL] [Abstract][Full Text] [Related]
11. Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis. Zezos P; Papaioannou G; Nikolaidis N; Vasiliadis T; Giouleme O; Evgenidis N Hepatogastroenterology; 2007; 54(77):1417-21. PubMed ID: 17708267 [TBL] [Abstract][Full Text] [Related]
12. Characterisation of the vascular plasminogen activator from the pig ear. Klöcking HP; Astedt B; Gerlach D Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):851-61. PubMed ID: 6083962 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160 [TBL] [Abstract][Full Text] [Related]
14. Ulcerative colitis: why is the mortality from cardiovascular disease reduced? Gyde SN; Prior P; Alexander F; Evans S; Taylor K; John WG; Waterhouse JA; Allan RN Q J Med; 1984; 53(211):351-7. PubMed ID: 6484117 [TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis]. Tymiński W; Czestochowska E; Swiecicki P Pol Tyg Lek; 1985 Oct; 40(43):1202-4. PubMed ID: 4088936 [No Abstract] [Full Text] [Related]
17. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis. Páramo JA; Alfaro MJ; Rocha E Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269 [TBL] [Abstract][Full Text] [Related]
18. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection. Chang LC; Meyerhoff ME; Yang VC Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738 [TBL] [Abstract][Full Text] [Related]
19. [Stability of tissue plasminogen activator]. Liutova LV; Andreenko GV; Shimonaeva EE Vopr Med Khim; 1985; 31(1):97-9. PubMed ID: 3920826 [TBL] [Abstract][Full Text] [Related]
20. [Identity of kininogenase and plasminogen activators in human granulocytes]. Ogloblina OG; Platonova LV; Paskhina TS; Martynov VF; Sorochinskaia EI Biokhimiia; 1984 Feb; 49(2):302-9. PubMed ID: 6424731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]